• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

George D. Yancopoulos - Articles and news items

SANOFI logo

Sanofi and Regeneron report positive top-line results with alirocumab from first Phase 3 study of a PCSK9 inhibitor for LDL cholesterol reduction

Industry news / 16 October 2013 / Sanofi

Alirocumab monotherapy reduced “bad” cholesterol three times more than ezetimibe…

Sanofi

Sanofi and Regeneron announce patient enrollment in two Phase 3 trials with sarilumab in RA

Industry news, News / 15 May 2013 / Sanofi

Comprehensive SARIL-RA development program to include 2,600 patients in four Phase 3 and one open-label extension trials…

Sanofi

Sanofi and Regeneron report positive proof-of-concept data for Dupilumab

Industry news, News / 2 March 2013 / Sanofi

Sanofi and Regeneron Pharmaceuticals, Inc. announced that pooled data from two Phase 1b trials with dupilumab…

Sanofi

ZALTRAP® (aflibercept) approved in the EU

Industry news, News / 5 February 2013 / Sanofi

First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen…

Sanofi

ZALTRAP® receives CHMP positive opinion in the European Union for previously treated mCRC

Industry news, News / 16 November 2012 / Sanofi

“We are pleased that CHMP has supported our ZALTRAP application…”

SANOFI logo
SANOFI logo
SANOFI logo

Sanofi and Regeneron report positive Phase 2b trial results with sarilumab in rheumatoid arthritis

Industry news, News / 12 July 2011 / Sanofi

Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials…

SANOFI logo

ZALTRAP™ (aflibercept) significantly improved survival in previously treated metastatic colorectal cancer patients

Industry news, News / 6 June 2011 / Sanofi

Data will be presented at the ESMO World Congress on Gastrointestinal Cancer…

 

Webinar: Different thermal analysis techniques to measure the glass transitionWATCH NOW
+ +